NINGXIA TAIYICIN BIOTECH CO. LTD
Ningxia Taiyicin Biotech Co., Ltd.(Former name Ningxia pacific Biotech Co.,Ltd.) was established in June, 2010. Its registered capital is RMB 6,250,000,00.00, locates in No.1 pacific road, Nuanquan technical area, Helan county ,Ningxia province. It is wholly owned subsidiary of Ningxia Tairui pharmaceutical CO..Ltd. Initially Taiyicin dedicated to produce Veterinary API Erythromycin Thiocyanate , based on that, we developed new Veterinary antibiotics and chemical synthesis products.
Since the establishment, Taiyicin relys on DuoWei’s superior resources, backed by National enterprise technological center, National biochemical engineering technical research center Shanghai Ningxia branch center and Country where joint engineering Lab, based on the standard of GMP certificate issued By national ministry of agriculture., ISO 9001 quality management system , ISO14001 environment management system , USFDA, Europe CEP and many other countries’ quality qualification, with China famous trademark”Tairui”, set a selling network covering more than 80 countries.”
Taiyicin produces annual 3000mts Erythromycin Thiocyanate in the first stage , covering an area of 574000 square meters , invested nearly 2000,000,000.00 Chinese yuan , and introduced international advanced equipment and National top level production process , started the construction in Sep,2010, and finished it in Oct,2012. Now the number of employees is up to more than 1000, the proportion of senior technical person is 22%. Now most of our products passed China agriculture administration GMP certificate and abtained the vet API manufacturing license.
Taiyicin plans to invest ten billion Chinese yuan for further construction occupied an area of 2000000 square meters to produce new products, and improve product additional value, extend the industrial chain through product update and optimizing the industrial structure. Moreover, we dedicate to the development of the industry of environmental protection and energy saving and the Enhancement of the capability of independent innovation.